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1. Introduction  
Rheumatoid arthritis (RA) is an autoimmune disorder that affects approximately 1% of 
adults in the United States (Alamanos and Drosos 2005). Clinically, RA is manifested by 
pain and swelling of joints, disability, and diminished overall patient well-being (Scott et al. 
2010). The etiology of RA remains enigmatic, but a range of genetic and environmental 
factors closely associated with RA have been identified over the past two decades. It is now 
known that the pathogenic process of RA involves the initiation and establishment of 
autoimmunity, followed by an inflammatory response, angiogenesis to maintain the chronic 
inflammatory state, and tissue degradation of the joint (Scott et al. 2010).  
Despite the advances in the pharmacological therapies of RA over the past years, most 
patients (85-90%) do not achieve full remission, with up to 15% showing little clinical 
improvement in outcomes (Geborek et al. 2002; van der Woude et al. 2009). Accumulating 
studies have demonstrated the effectiveness of non-drug treatment modalities, e.g. exercise 
and physical activity, as an adjunct to drug therapy in patients with RA (Stenstrom and 
Minor 2003; Lundberg and Nader 2008). As a result, physical training is now a standard part 
of treatment for RA patients.  
This chapter will first review results from randomized clinical trials which investigated the 
effects of exercise on RA disease activity. In RA patients, exercise was demonstrated to 
improve physical performance, cardiorespiratory fitness and muscle strength without 
worsening joint inflammation (Ekblom et al. 1975). Subsequent clinical studies have not only 
shown that exercise leads to meaningful effects on physical performance and fitness, but 
exercise can also reduce RA disease activity, measured by the number of swollen or tender 
joints (Stenstrom and Minor 2003). At the systemic level, there are several reports indicating 
a reduction in circulating levels of inflammatory biomarkers following long-term physical 
exercise (Dekker et al. 2007; Olson et al. 2007). These beneficial effects of exercise have been 
observed following different types of physical activity, after short-term and long-term (>2 
years) exercise programs, at different phases of the disease course, and even in patients with 
high disease activity (van den Ende et al. 2000; Stenstrom and Minor 2003).  
Next, by focusing on the effects of exercise, delivered in the form of physiologically relevant 
mechanical loading, this review will provide updated insights into exercise at both the 
systemic and local (e.g. cartilage and synovium) levels. Studies indicate that exercise 
www.intechopen.com
 Rheumatoid Arthritis – Treatment 
 
312 
activates an anti-rheumatologic response which includes an inhibition of pro-inflammatory 
cytokines such as tumor necrosis factor-alpha (TNF-ǂ) in healthy and diabetic patients 
(Lundberg and Nader 2008). There is also evidence regarding the potential beneficial effects 
of exercise in preventing or suppressing the destructive consequences of inflammation in 
joint tissues (Ferretti et al. 2005; Ferretti et al. 2006). Clearly, the mechanical loading 
component of the exercise stimulus might be one of the mechanisms by which exercise 
exerts a protective anti-inflammatory effect at the local tissue level by preventing the 
expression of pro-inflammatory molecules. For example, studies have shown that moderate 
mechanical loading in vitro and in vivo upregulate production of anti-inflammatory 
cytokines interleukin (IL)-4 and IL-10, and suppress expression of IL-1ǃ (Millward-Sadler 
and Salter 2004; Ferretti et al. 2005).  
This will be followed by a discussion of how anti-inflammatory cytokines may work in 
concert with the anti-catabolic nature of physiologic biomechanical signals to mediate the 
protective effects of exercise. Elevated levels of pro-inflammatory cytokines such as IL-1ǃ 
and TNF-ǂ stimulate production of proteolytic enzymes matrix metalloproteinases (MMPs) 
and A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) which 
mediate the cartilage destruction process in RA (Sun 2010). Studies have demonstrated 
physiological loading suppresses MMP and ADAMTS expression in both inflamed and non-
inflamed joints to exert protective effects on the synovium and articular cartilage (Ferretti et 
al. 2005; Ferretti et al. 2006; Leong et al. 2010). The most recent progress on these 
mechanotransduction pathways which regulate the loading-induced anti-inflammatory and 
anti-catabolic responses will be presented, as well as possible crosstalk between these two 
pathways. 
The chapter will conclude with perspectives on how identification of the signaling pathways 
activated by exercise will lead to the discovery of new treatment targets and development of 
novel treatment strategies which may have significant clinical potential in treating 
rheumatoid arthritis. 
2. Exercise in rheumatoid arthritis treatment 
The primary goals of RA treatment are to suppress inflammation and limit or prevent joint 
damage, while relieving pain and improving the patients’ quality of life (Kowh et al. 2002). 
There is currently no cure for rheumatoid arthritis and treatment strategies involve a 
combination of drugs as well as non-pharmacologic treatments such as exercise and 
physical therapy (Smolen et al. 2010). As soon as the diagnosis for RA is established, 
prescribed medications include disease-modifying antirheumatic drugs (DMARDs), non-
steroidal anti-inflammatory drugs, glucocorticoids, and TNF‑ǂ inhibitors (Deighton et al. 
2009; Bijlsma 2010).  
Although drug treatment helps improve disease outcome, exercise is still a vital part of 
rheumatoid arthritis treatment. For the general adult population, the American College of 
Sports Medicine and the Heart Association recommends at least 30 minutes of moderate-
intensity exercise five days a week (Haskell et al. 2007). The benefits of regular exercise for 
healthy adults are well accepted, and include reducing the risk of coronary artery disease 
and improving cardiovascular health (Muller-Riemenschneider et al. 2011), reducing 
adiposity (Brukner and Brown 2005), and increasing muscle strength (Brentano and Martins 
Kruel 2011; Peterson and Gordon 2011). Randomized clinical trials have reported that the 
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health benefits of exercise are also obtained in patients with RA without adverse effects on 
disease activity (van den Ende et al. 2000; de Jong et al. 2003; Bilberg et al. 2005; Melikoglu et 
al. 2006; van den Berg et al. 2006; Neuberger et al. 2007; Baillet et al. 2009; Lemmey et al. 
2009). Furthermore, exercise at a high intensity, but within a physiologic range, was more 
effective in increasing physical function when compared to low intensity exercise (van den 
Ende et al. 2000; Lemmey et al. 2009). 
2.1 Description of prescribed exercises 
Based on the beneficial effects of physical activity in RA clinical trials, exercise programs for 
people with RA typically involve a combination of stretching exercises, aerobic training, and 
strength training (Stenstrom and Minor 2003; Cairns and McVeigh 2009; Forestier et al. 2009; 
Hurkmans et al. 2009; Baillet et al. 2010; Metsios et al. 2010). Table 1 summarizes commonly 
prescribed modes of exercise and their recommended doses (Resnick 2001; Medicine et al. 
2009). Exercise programs are initially prescribed and supervised by an experienced 
professional, who tailors the program according to the patient’s disease activity and 
symptoms (de Jong and Vliet Vlieland 2005). Since many RA patients have severe disability 
and a below average physical capacity, the intensity of training is initially low and gradually 
increased. If pain or swelling appears during exercise, patients are advised to reduce 
exercise intensity and/or duration until the pain or swelling subsides. 
Daily stretching is recommended to decrease joint stiffness and maintain or increase pain-
free range of motion (ROM). Patients with RA should begin their exercise programs with 
two to three daily repetitions of each stretching and ROM exercise, and eventually progress 
to 10 repetitions daily (Nieman 2000; Medicine et al. 2009). Range of motion exercises should 
be performed slowly with appropriate support, and should not be attempted in a rapid 
manner with bouncing movements (Resnick 2001). 
Walking, cycling, rowing, swimming, water aerobics, and dance are examples of aerobic 
exercises prescribed to RA patients. Regular brisk walking in previously sedentary adults 
improved aerobic fitness and reduced cardiovascular risk in healthy adults (Murphy et al. 
2002). Cycling at 70-80% predicted maximum heart rate significantly improved aerobic 
capacity, muscle strength, and joint mobility in RA individuals when compared to patients 
who only performed ROM exercises (van den Ende et al. 1996). Hydrotherapy, which 
combines elements of warm water immersion and exercise, was reported to improve the 
physical and emotional states of RA patients. Specifically, there was a reduction in joint 
tenderness and an improvement in knee range of motion, and emotional and physiological 
well-being (Hall et al. 1996). Moderately intensive pool exercise therapy in patients with RA 
did not improve aerobic capacity, but there were significant improvements in the muscle 
endurance in the lower and upper extremities (Bilberg et al. 2005). Although dance 
programs are not well-studied in the RA population, one study did report that female 
participants in a four week dance-based exercise program involving slow body movements 
exhibited significant improvements in locomotor ability (Moffet et al. 2000). 
Loss of muscle mass and strength is a common characteristic in RA patients (Pedersen and 
Saltin 2006), and therefore muscle strengthening exercises are often recommended. These 
high-intensity training exercises include the leg press, chest press, leg extension, seated 
rowing, leg curl, triceps extension, standing calf raises, and bicep curl (Lemmey et al. 2009). 
Progressive resistance training (PRT) programs involving the large muscle groups as well as 
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hand exercises have demonstrated improvements in physical function, increase in muscle 
mass, and reduction in fat mass (Hakkinen et al. 2005; Marcora et al. 2005; Lemmey et al. 
2009). Early RA patients who enrolled in a two year strength training program exhibited 
significant improvements not only in muscle strength, but also showed reductions in 
systemic inflammation, pain, and disease activity (Hakkinen et al. 2001). With continued 
training, these gains in muscle strength can be maintained (de Jong et al. 2009). 
 
Class of Exercise Type of exercise Recommended 
intensity/frequency/duration 
Flexibility Stretching 
 
 
Range of motion 
Daily, before and after aerobic 
exercise. Hold stretch for 10-30 
seconds, 3-5 repetitions  
Full range of motion for all joints 
daily 
Aerobic Walking 
Cycling 
60-80% maximum heartrate 
Up to 30 minutes/session 
Rowing 3-5 days/week 
Swimming 
Water aerobics 
 
Dance  
Strength Free weights 
Weight machines 
Elastic bands 
At least 1 set of 2-3 reps (up to 3 
sets of 10 reps) at 80% of the 1-
repetition maximum (the 
maximum load lifted for each of 
the prescribed exercises) 
2-3 days/week 
 
 
Table 1. Exercise management guidelines for the treatment of RA (Resnick 2001; Lemmey et 
al. 2009; Medicine et al. 2009) 
2.2 Beneficial effects of exercise in RA  
Many RA patients suffer from cachexia, which is characterized by a decrease in muscle mass 
along with an increase in fat mass. This is unlike the cachexia associated with conditions 
such as HIV-AIDS, cancers, chronic obstructive pulmonary disease (COPD), and old age, 
which is defined by significant muscle wasting alone, and is usually characterized by weight 
loss (Roubenoff et al. 1992). These changes in body composition may increase the risk of 
developing diabetes and cardiovascular disease (Roubenoff et al. 1992; Lavie et al. 2009), as 
well as lead to muscle weakness, decreased physical activity, pain, and fatigue, which 
together further adversely affect skeletal health (Hakkinen 2004). Muscle strengthening is 
important not only to regain normal physical function, but it is also necessary for joint 
stability, which may protect against the development of osteoarthritis (Sun 2010). Exercise 
has been demonstrated to significantly improve many of the symptoms of rheumatoid 
arthritis, including disability, pain, joint stiffness and fatigue (Hakkinen 2004; Marcora et al. 
2005; Neill et al. 2006; Brorsson et al. 2009; Lemmey et al. 2009). Progressive resistance 
training was reported to increase muscle mass, improve physical function, and reduce 
disabilities associated with RA (Marcora et al. 2005; Lemmey et al. 2009). High intensity 
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resistance exercise also has been reported to reverse RA cachexia by restoring muscle mass 
(Marcora et al. 2005).  
Because of RA cachexia, it was hypothesized that patients with RA were resistant to the 
anabolic effects of exercise (Rall et al. 1996). However, no differences in the physiological 
properties of muscle that determine force, including contractile properties, voluntary 
activation capacity, and contraction velocity, were found between cachectic RA patients and 
healthy controls (Matschke et al. 2010). Recent clinical trials have found that the muscle of 
RA patients respond in similar manner to that of muscle in healthy individuals. The 
strengthening effects of PRT in RA patients (Lemmey et al. 2009) are similar to those 
observed in healthy middle-aged subjects (Morse et al. 2007). Studies which directly 
compared RA patients with age-matched healthy patients reported similar findings. 
Following resistance and aerobic exercise training, comparable increases in strength and 
thigh muscle cross-section, and decreases in thigh fat thickness were found in both RA and 
healthy female patients (Hakkinen et al. 2005). Together, these studies demonstrate that 
exercise training increases muscle mass, strength, and improves physical function in a 
similar manner in patients with RA and in healthy individuals. In fact, the inclusion of high-
intensity PRT is recommended in RA treatment strategies to counteract the effects of 
rheumatoid cachexia (Pedersen and Saltin 2006; Lemmey et al. 2009).  
2.3 Anti-inflammatory effects of exercise 
Regular exercise, such as endurance training, can reduce basal levels of many inflammatory 
mediators/markers (King et al. 2003). Consequently, exercise has been recommended as an 
anti-inflammatory therapy in chronic inflammatory disorders such as RA (Kowh et al. 2002), 
and its effects are observed on the systemic and local levels. 
2.3.1 Systemic effects 
Physical inactivity, a common consequence of RA symptoms, leads to the accumulation of 
visceral fat and activation of inflammatory pathways (Walsh et al. 2011). Chronic 
inflammation can also drive the development of insulin resistance and atherosclerosis 
(Handschin and Spiegelman 2008). Increased physical activity has been reported to reduce 
inflammation in non-RA patients, as indicated by a downregulation of inflammation 
markers/mediators (Petersen and Pedersen 2005). In another demonstration of the anti-
inflammatory effects of exercise, a model of low grade inflammation was established in 
healthy volunteers through the administration of a low dose of E. coli endotoxin. While 
circulating levels of TNF-ǂ were increased in resting individuals, this increase was blocked 
in subjects who exercised prior to the endotoxin administration (Starkie et al. 2003), 
suggesting exercise may inhibit the production of TNF-ǂ. Together, it is possible the anti-
inflammatory effects of exercise are due to a decrease in visceral fat mass as well as the 
production of anti-inflammatory factors. 
With exercise, there is a release of inflammatory-related cytokines from muscle into the 
circulation. IL-6 is the first cytokine released during exercise.  Levels of circulating IL-6 
increase exponentially after exercise and then decline post-exercise (Petersen and Pedersen 
2006, Walsh et al. 2011).  It is unclear whether this acute elevation in IL-6 modulates 
inflammatory processes during physical activity.  Although IL-6 is a pro-inflammatory 
cytokine in the rheumatic joint, recent studies suggest the transient response of IL-6 may 
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play a metabolic, rather than an immunological role (Walsh et al. 2011).  Following the 
increase of IL-6 in response to exercise in healthy individuals, IL-10 and IL-1 receptor 
antagonist (IL-1ra) are released into the circulation (Petersen and Pedersen 2006). Notably, 
an infusion of IL-6 enhanced plasma levels of IL-1ra and IL-10, (Steensberg et al. 2003). This 
suggests that the anti-inflammatory effect of exercise can be attributed, at least in part, to the 
induction of IL-6 and the creation of an anti-inflammatory environment (Table 2). Of note, 
no changes in serum IL-6 were detected in RA patients after exercise, but this might be 
attributable to a less strenuous exercise regimen when compared to healthy individuals 
(Knudsen et al. 2008). It is also possible that the anti-inflammatory effect of exercise is 
blunted in patients with RA, but this requires further study. 
 
Type of exercise Beneficial effect on health 
Aerobic exercise (humans) Increase plasma levels of IL-10, IL-1ra 
(Walsh et al. 2011) 
Cycling (humans) Suppress endotoxin-induced TNF-ǂ 
(Starkie et al. 2003) 
Strength training (humans) Increase IL-15 
(Pedersen and Febbraio 2008) 
Continuous passive motion (rabbits) Suppression of proteoglycan loss  
Downregulation of MMP-1  
Upregulation of IL-10 
(Ferretti et al. 2005; Ferretti et al. 2006) 
Continuous passive motion (rats) Suppression of proteoglycan loss 
Downregulation of MMP-1, -3  
(Leong et al. 2010; Leong et al. 2011) 
Table 2. Anti-inflammatory and anti-catabolic effects of exercise 
2.3.2 Local effects on cartilage 
Clinical trials investigating the anti-inflammatory effect of exercise in the articular cartilage 
of RA patients are lacking, but results from clinical studies of osteoarthritis patients and 
animal models of RA suggest that moderate exercise has an anti-inflammatory effect on 
cartilage. Following acute resistance exercise, a significant increase in IL-10 was observed in 
the intra-articular and synovial spaces of subjects who exercised when compared to a non-
exercise group (Helmark et al. 2010). Increases in IL-10 expression were also reported in 
chondrocytes in antigen-induced arthritis, an animal model of rheumatoid arthritis, after 
two weeks of continuous passive motion when compared to immobilized joints (Ferretti et 
al. 2005; Ferretti et al. 2006). Continuous passive motion also suppressed expression of IL-1ǃ 
and inflammatory mediator COX-2 (Ferretti et al. 2006). Together, these data suggest that 
physiologic loading has the potential to generate anti-inflammatory biomechanical signals 
in cartilage, at least in part, by inducing IL-10.  
To test the direct effect of IL-10 on rheumatic activity, collagen-induced arthritis mice were 
treated with recombinant IL-10, which resulted in a mild, but significant suppression of 
arthritic phenotype/symptoms (Johansson et al. 2001). Endogenous IL-10 plays a pivotal 
role in the regulation of antigen (streptococcal cell wall)-induced arthritis (Lubberts et al. 
1998), since the blocking of endogenous IL-10 with anti-IL-10 antibodies resulted in a 
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sustained arthritis with denser synovial infiltrates as well as enhanced cartilage damage. 
Adding exogenous IL-10 further enlarged the suppressive effect of endogenous IL-10. 
However, these findings require further investigation in human clinical trials of RA patients. 
2.4 Anti-catabolic effects of exercise on cartilage 
Considering cartilage destruction is a hallmark of RA, the role of exercise in maintaining 
cartilage matrix integrity is of great importance (Table 2) (Maini and Feldmann 2004). 
Articular cartilage functions as a nearly frictionless bearing surface while uniformly 
transferring loads on underlying bone and preventing high stress concentrations. 
Cartilage consists of one cell type, the chondrocyte, embedded in an extracellular matrix 
of mainly type II collagen and proteoglycans (Milner 2008). Physiologic loading of the 
cartilage tissue is required to maintain tissue homeostasis, while non-physiologic loading 
(disuse and overuse) promotes its degradation (Sun 2010). Intensive dynamic and weight-
bearing exercises were originally considered detrimental for patients with RA due to 
concerns of exacerbating disease, (van den Ende et al. 1996), but studies have shown such 
exercise does not cause an increase in the rate of damage to either large (de Jong et al. 
2003) or small joints (de Jong et al. 2004). There were no significant differences in the rate 
of damage of large joints 18 months following the end of a high-intensity program 
between RA patients who discontinued exercise and those who were still exercising (de 
Jong et al. 2009). Furthermore, levels of cartilage oligomeric matrix protein (COMP), a 
measure of cartilage damage were unchanged after 3 months of exercise in RA patients, 
suggesting exercise did not cause significant damage to the cartilage matrix (de Jong et al. 
2008). Exercise may also enhance joint lubrication, further acting to promote the health of 
the RA joint. During joint movement, synovial fluid is squeezed out from between the two 
surfaces of the joint, resulting in fluid film lubrication (Isenberg et al. 2004). Lubricin, a 
mucinous glycoprotein secreted by synovial fibroblasts, is the factor responsible for 
lubrication (Jay et al. 2001), and reduced levels of this protein found in RA patients may 
increase joint friction and promote cartilage degradation (Jay et al. 2004; Elsaid et al. 
2007). However, whether exercise increases lubricin expression in patients with RA has 
not yet been determined. Exercise also promotes adequate strength of the muscles and 
surrounding joint soft tissues, providing optimal joint stability, alignment and attenuation 
of impact and compressive forces (Sun 2010). 
After vigorous exercise in patients with moderate disease activity, a reduction in the 
number of diseased joints is observed (Minor et al. 1989; van den Ende et al. 1996). Animal 
studies have demonstrated physiologic loading of joints exerts beneficial effects by 
suppressing the activity of proteolytic enzymes in healthy and arthritic rats. Passive joint 
motion prevented cartilage destruction due to inactivity and downregulated MMPs 1 and 
3 (Leong et al. 2010; Leong et al. 2011). In antigen-induced rabbits, passive motion 
prevented proteoglycan loss and suppressed expression of MMP-1 (Ferretti et al. 2005; 
Ferretti et al. 2006).  
3. Mechanisms of exercise in rheumatoid arthritis treatment 
Although the beneficial effects of exercise for rheumatoid arthritis patients are well 
documented, the mechanisms are still largely unclear.  As detailed previously, the effects of 
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exercise are commonly characterized as anti-inflammatory and anti-catabolic. Each of these 
components is mediated by distinct signalling pathways and evidence indicates crosstalk 
between these pathways (see Figure 1 for hypothesized pathways/mechanisms). 
3.1 Anti-inflammatory signaling 
One of the first evidences of anti-inflammatory signalling in chondrocytes was the 
elucidation of the ǂ5ǃ1 integrin/IL-4 pathway. In this pathway, mechanical stimulation 
of normal chondrocytes acts through the ǂ5ǃ1 integrin to release IL-4, which acts in an 
autocrine/paracrine manner. Following IL-4 release, there is a decrease in MMP-3 and an 
increase in aggrecan mRNA, resulting in a net increase in cartilage extracellular matrix 
production (Millward-Sadler and Salter 2004). The transcription factor Signal Transducer 
and Activator of Transcription 6 (STAT6) plays a principal role in IL-4 signaling as 
demonstrated in mice lacking STAT6 that show a similar phenotype as mice lacking the 
IL-4 receptor alpha (IL-4Rǂ) (Takeda et al. 1996). IL-4 stimulates intracellular signaling 
pathways including the recruitment of STAT6 to the IL-4Rǂ. STAT6 binds to specific 
phosphotyrosine residues within the IL-4Rǂ (Ryan et al. 1998). In this complex, STAT6 is 
quickly phosphorylated by a JAK-dependent mechanism. After phosphorylation, STAT6 
leaves the receptor, dimerizes, and migrates to the nucleus where it binds to specific 
DNA sequences in the promoter of genes (Darnell 1997). It is believed that STAT6 is 
tightly regulated, because in the absence of IL-4 stimulation, STAT6 is quickly 
deactivated (Andrews et al. 2002). Methylation of STAT6 is a regulator of STAT6 activity, 
necessary for optimal STAT6 phosphorylation, nuclear translocation, and DNA-binding 
activity (Chen et al. 2004). Accumulating evidence suggests that IL-4 STAT6 is a central 
anti-rheumatoid signaling pathway because it upregulates three factors known to 
antagonize the actions of specific pro-inflammatory agents implicated in RA: (1) soluble 
IL-1 receptor antagonist (sIL-1ra); (2) tristetraprolin (TTP), which antagonizes TNF-ǂ; 
and (3) the ǃ3 integrin, which was shown to antagonize the angiogenic actions of 
vascular endothelial growth factor (VEGF) (Vannier et al. 1992; McHugh et al. 2001; 
Suzuki et al. 2003).  
While the mechanisms underlying the anti-inflammatory effects of IL-10 are largely 
unknown in chondrocytes, studies which overexpress IL-10 provide insight on the 
downstream targets of IL-10. IL-10 treatment in an antigen-induced arthritis animal model 
resulted in a marked reduction of TNF-ǂ levels (Lubberts et al. 1998). In human 
chondrocytes treated with TNF-ǂ, IL-10 overexpression ssuppressed MMP-13 levels and 
antagonized the TNF-ǂ-mediated suppression of aggrecan (Muller et al. 2008). It has been 
hypothesized that IL-10 may exert its effects by stimulating the production of endogenous 
TNF-ǂ inhibitors such as soluble TNF-ǂ receptors (Fernandes et al. 2002). 
3.2 Anti-catabolic signaling 
In vivo, motion-based therapies have been demonstrated to mitigate joint inflammation in 
animal models of antigen-induced arthritis. Mechanical signals generated from these 
passive joint motion therapies were reported to be potent inhibitors of pro-inflammatory 
gene induction and inhibit expression of catabolic mediators, e.g., IL-1ǃ, COX-2, and MMP-1 
(Ferretti et al. 2005; Ferretti et al. 2006). At low magnitudes in vitro, biomechanical signals 
inhibit IL-1ǃ- or TNF-ǂ-induced transcriptional activation of COX-2, MMPs, IL-1ǃ, and 
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other pro-inflammatory molecules (Chowdhury et al. 2003; Agarwal et al. 2004; Ferretti et al. 
2005; Chowdhury et al. 2006; Deschner et al. 2006).  
Exposure of meniscal or articular chondrocytes to proinflammatory cytokines (e.g. IL-1ǃ and 
TNF-ǂ) is reported to result in the expression of cyclo-oxygenase 2, inducible nitric oxide 
synthase, and genes involved in cartilage catabolism, such as matrix metalloproteinases 9 
and 13 (Gassner et al. 1999). By contrast, when cells are subjected to mechanical stimuli in 
the form of cyclic tensile strain, they display a blunted response to cytokine exposure, 
thereby antagonizing the proinflammatory and catabolic effects of these cytokines (Ferretti 
et al. 2006; Madhavan et al. 2006). Interestingly, this anti-catabolic response seems to be 
mediated by inhibition of nuclear translocation of Nuclear factor-kappa B (NF-κB) and 
modulation of upstream signaling events associated with NF-κB, suggesting that mechanical 
activity can act at multiple points within the proinflammatory signaling network to 
counteract cytokine-induced proinflammatory gene expression (Dossumbekova et al. 2007). 
NF-κB transcription factors regulate a wide range of pro-inflammatory and anti-apoptotic 
genes, and are involved in both acute and chronic inflammatory responses. NF-κB is a rapid 
response, multiple-stimuli inducible transcription factor that is controlled by sequential 
signal activation cascades (Seguin and Bernier 2003). In the classical NF-κB signaling 
pathway, binding of pro-inflammatory mediators, such as IL-1ǃ, TNF-α, and/or LPS to their 
cognate receptors leads to activation of a series of receptor-associated signaling molecules 
leading to activated NF-κB, which translocates to the nucleus, where it binds to the 
consensus sequences of several genes including pro-inflammatory cytokines and mediators 
(Ghosh and Karin 2002; Hoffmann et al. 2002; Liacini et al. 2003). Mechanical signals of 
low/physiological magnitudes block the IL-1ǃ-induced transcriptional activity of NF-κB by 
intercepting multiple steps in the NF-κB signaling cascade. In chondrocytes, cyclic tensile 
strain of low magnitudes does not appear to inhibit IL-1ǃ, TNF-ǂ, or LPS receptor-mediated 
pro-inflammatory gene induction (Agarwal et al. 2004; Dossumbekova et al. 2007; 
Madhavan et al. 2007). These findings suggest that mechanical signals use specific target 
sites to trigger NF-κB signaling. 
Another transcriptional regulator which plays a critical role in cartilage homeostasis is 
CBP/p300-interacting transactivator with ED-rich tail 2 (CITED2). CITED2 expression is 
increased by moderate flow shear (5 dyn/cm2), intermittent hydrostatic pressure (1-5 
MPa), and joint motion (Yokota et al. 2003; Leong et al. 2011). The induction of CITED2 in 
vivo by joint motion loading was correlated with the downregulation of MMP-1 and the 
maintenance of cartilage matrix integrity (Leong et al. 2011), suggesting it plays a key role 
in mediating the anti-catabolic effects of moderate loading. The induction of CITED2 by 
physiologic loading was mediated by mitogen-activated protein kinase (MAPK) p38δ, and 
CITED2 regulated the transcription of MMPs (ie. MMP-1) by competing with MMP 
transactivator ETS-1 for binding to limiting amounts of co-activator p300 (Leong et al. 
2011). 
3.3 Crosstalk between anti-inflammatory and anti-catabolic responses 
There is also evidence of crosstalk between the anti-inflammatory and anti-catabolic 
pathways. CITED2, induced by p38δ, has also been demonstrated to be upregulated in 
response to IL-4 (Sun et al. 1998), raising the possibility these two pathways could work in 
synergy. Furthermore, treatment strategies involving gene transfer of IL-4 or IL-10 
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combined with mechanical stimulation may augment the chondroprotective effects of 
exercise. However, these hypotheses still require further investigation. 
 
 
Fig. 1. Hypothesized anti-inflammatory and anti-catabolic mechanisms underlying the 
effects of exercise in suppressing cartilage destruction in arthritis. 
4. Conclusion 
Compelling evidence suggests that physiologic exercise exerts beneficial effects in 
rheumatoid arthritis patients that not only increases quality of life but also suppresses 
disease activity. The beneficial effects are dependent on the mechanical nature of exercise, 
including the loading intensity, frequency, and duration. Exercise regimens may have 
varying effects with age and stage of disease. Furthermore, elucidating mechanisms 
underlying these beneficial effects of exercise may lead to the development of novel 
therapeutic strategies to prevent joint destruction in rheumatoid arthritis. 
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